Whether a patient with mycoplasma pneumonia can be infused on an outpatient basis is determined by the pneumonia CURB-65 score, and hospitalization is recommended if the CURB-65 score is ≥2. The CURB-65 score is used to assess the severity of a patient’s condition, which is used as a basis for determining the need for hospitalization.The clinical indicators of the CURB-65 score include: impaired consciousness, blood urea nitrogen, respiratory rate, blood pressure, and age. If a patient with mycoplasma pneumonia has a CURB-65 score of ≤1, he or she may choose to be treated with an outpatient infusion or be treated outside the hospital. If CURB-65 score = 2, admission to the hospital for short-term inpatient treatment is recommended. If the CURB-65 score ≥3, it suggests a more serious condition and prompt hospitalization or ICU treatment is recommended. For the presence of underlying diseases such as chronic cardiovascular and cerebrovascular diseases, liver and renal insufficiency, timely specialist consultation is recommended for further evaluation and decision on outpatient or inpatient treatment.